<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>38 patients diagnosed as <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were retrospectively evaluated for clinical course, prognostic factors, diagnostical power of cytology and histology and relevance of hypoplastic <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Median observation time was 14.5 (0 to 104) months </plain></SENT>
<SENT sid="2" pm="."><plain>15 patients (40%) developed an <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> after two to 67 (median eleven) months </plain></SENT>
<SENT sid="3" pm="."><plain>Prognosis was negatively influenced by age, suggested myelotoxic agents in prior history and <z:hpo ids='HP_0001909'>leukemia</z:hpo> in first-grade relatives as well as ESR greater than or equal to 30 mm Hg (first hour) </plain></SENT>
<SENT sid="4" pm="."><plain>FAB-classification and Bournemouth-score reflected prognosis in respect to survival time and development of an <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Cytology and histology revealed contradictory results in four of 14 comparable cases (28.6%) </plain></SENT>
<SENT sid="6" pm="."><plain>Hypoplastic <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> was diagnosed by histology in seven out of eight cases </plain></SENT>
<SENT sid="7" pm="."><plain>This entity showed significantly lower WBC-values and a considerable longer survival time </plain></SENT>
</text></document>